nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Vitamin B12 deficiency—Metformin—polycystic ovary syndrome	0.151	0.207	CcSEcCtD
Esomeprazole—ATP4B—endocrine gland—polycystic ovary syndrome	0.0322	0.222	CbGeAlD
Esomeprazole—CYP2C19—urine—polycystic ovary syndrome	0.0295	0.204	CbGeAlD
Esomeprazole—ATP4A—adrenal cortex—polycystic ovary syndrome	0.0224	0.155	CbGeAlD
Esomeprazole—Fungal infection—Metformin—polycystic ovary syndrome	0.0205	0.0282	CcSEcCtD
Esomeprazole—Omeprazole—CYP11A1—polycystic ovary syndrome	0.0199	0.456	CrCbGaD
Esomeprazole—Rigors—Metformin—polycystic ovary syndrome	0.0193	0.0267	CcSEcCtD
Esomeprazole—Accidental injury—Metformin—polycystic ovary syndrome	0.0179	0.0246	CcSEcCtD
Esomeprazole—CYP3A4—urine—polycystic ovary syndrome	0.0175	0.121	CbGeAlD
Esomeprazole—ATP4A—adrenal gland—polycystic ovary syndrome	0.0162	0.112	CbGeAlD
Esomeprazole—Lightheadedness—Metformin—polycystic ovary syndrome	0.0141	0.0195	CcSEcCtD
Esomeprazole—ATP4A—endocrine gland—polycystic ovary syndrome	0.014	0.0968	CbGeAlD
Esomeprazole—Ear pain—Metformin—polycystic ovary syndrome	0.0134	0.0185	CcSEcCtD
Esomeprazole—Injury—Metformin—polycystic ovary syndrome	0.0125	0.0172	CcSEcCtD
Esomeprazole—Renal impairment—Metformin—polycystic ovary syndrome	0.012	0.0166	CcSEcCtD
Esomeprazole—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0117	0.0162	CcSEcCtD
Esomeprazole—Pain in extremity—Metformin—polycystic ovary syndrome	0.0115	0.0158	CcSEcCtD
Esomeprazole—Migraine—Metformin—polycystic ovary syndrome	0.0113	0.0156	CcSEcCtD
Esomeprazole—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0105	0.0144	CcSEcCtD
Esomeprazole—Breast disorder—Metformin—polycystic ovary syndrome	0.0104	0.0143	CcSEcCtD
Esomeprazole—Cramp muscle—Metformin—polycystic ovary syndrome	0.0103	0.0142	CcSEcCtD
Esomeprazole—Abdominal distension—Metformin—polycystic ovary syndrome	0.00998	0.0137	CcSEcCtD
Esomeprazole—Influenza—Metformin—polycystic ovary syndrome	0.00991	0.0137	CcSEcCtD
Esomeprazole—Pancreatitis—Metformin—polycystic ovary syndrome	0.00972	0.0134	CcSEcCtD
Esomeprazole—Sweating increased—Metformin—polycystic ovary syndrome	0.00965	0.0133	CcSEcCtD
Esomeprazole—Angina pectoris—Metformin—polycystic ovary syndrome	0.00965	0.0133	CcSEcCtD
Esomeprazole—Neutropenia—Metformin—polycystic ovary syndrome	0.00927	0.0128	CcSEcCtD
Esomeprazole—Rabeprazole—CYP1A1—polycystic ovary syndrome	0.00926	0.213	CrCbGaD
Esomeprazole—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00921	0.0127	CcSEcCtD
Esomeprazole—Infestation—Metformin—polycystic ovary syndrome	0.00884	0.0122	CcSEcCtD
Esomeprazole—Infestation NOS—Metformin—polycystic ovary syndrome	0.00884	0.0122	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00836	0.0115	CcSEcCtD
Esomeprazole—Bradycardia—Metformin—polycystic ovary syndrome	0.00808	0.0111	CcSEcCtD
Esomeprazole—Rhinitis—Metformin—polycystic ovary syndrome	0.00795	0.011	CcSEcCtD
Esomeprazole—Hepatitis—Metformin—polycystic ovary syndrome	0.00793	0.0109	CcSEcCtD
Esomeprazole—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00789	0.0109	CcSEcCtD
Esomeprazole—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00781	0.0108	CcSEcCtD
Esomeprazole—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00779	0.0107	CcSEcCtD
Esomeprazole—Omeprazole—CYP1A1—polycystic ovary syndrome	0.00755	0.173	CrCbGaD
Esomeprazole—Eye disorder—Metformin—polycystic ovary syndrome	0.00741	0.0102	CcSEcCtD
Esomeprazole—Flushing—Metformin—polycystic ovary syndrome	0.00736	0.0101	CcSEcCtD
Esomeprazole—Immune system disorder—Metformin—polycystic ovary syndrome	0.00716	0.00987	CcSEcCtD
Esomeprazole—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00715	0.00985	CcSEcCtD
Esomeprazole—Chills—Metformin—polycystic ovary syndrome	0.00712	0.00981	CcSEcCtD
Esomeprazole—Lansoprazole—CYP1A1—polycystic ovary syndrome	0.00691	0.159	CrCbGaD
Esomeprazole—Malnutrition—Metformin—polycystic ovary syndrome	0.00691	0.00951	CcSEcCtD
Esomeprazole—Flatulence—Metformin—polycystic ovary syndrome	0.0068	0.00938	CcSEcCtD
Esomeprazole—Dysgeusia—Metformin—polycystic ovary syndrome	0.00676	0.00932	CcSEcCtD
Esomeprazole—Muscle spasms—Metformin—polycystic ovary syndrome	0.00664	0.00915	CcSEcCtD
Esomeprazole—Vision blurred—Metformin—polycystic ovary syndrome	0.00651	0.00897	CcSEcCtD
Esomeprazole—Tremor—Metformin—polycystic ovary syndrome	0.00647	0.00891	CcSEcCtD
Esomeprazole—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00641	0.00883	CcSEcCtD
Esomeprazole—Malaise—Metformin—polycystic ovary syndrome	0.00623	0.00858	CcSEcCtD
Esomeprazole—Palpitations—Metformin—polycystic ovary syndrome	0.0061	0.00841	CcSEcCtD
Esomeprazole—Hypertension—Metformin—polycystic ovary syndrome	0.00596	0.00821	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00589	0.0686	CbGpPWpGaD
Esomeprazole—Myalgia—Metformin—polycystic ovary syndrome	0.00588	0.0081	CcSEcCtD
Esomeprazole—Chest pain—Metformin—polycystic ovary syndrome	0.00588	0.0081	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00584	0.00804	CcSEcCtD
Esomeprazole—Discomfort—Metformin—polycystic ovary syndrome	0.00581	0.008	CcSEcCtD
Esomeprazole—Infection—Metformin—polycystic ovary syndrome	0.0056	0.00771	CcSEcCtD
Esomeprazole—Shock—Metformin—polycystic ovary syndrome	0.00554	0.00764	CcSEcCtD
Esomeprazole—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00553	0.00762	CcSEcCtD
Esomeprazole—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00552	0.0076	CcSEcCtD
Esomeprazole—Skin disorder—Metformin—polycystic ovary syndrome	0.00547	0.00754	CcSEcCtD
Esomeprazole—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00545	0.00751	CcSEcCtD
Esomeprazole—Anorexia—Metformin—polycystic ovary syndrome	0.00537	0.0074	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00533	0.0621	CbGpPWpGaD
Esomeprazole—ATP4A—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00525	0.0612	CbGpPWpGaD
Esomeprazole—CYP2C19—vagina—polycystic ovary syndrome	0.00524	0.0361	CbGeAlD
Esomeprazole—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00513	0.00707	CcSEcCtD
Esomeprazole—Paraesthesia—Metformin—polycystic ovary syndrome	0.00506	0.00697	CcSEcCtD
Esomeprazole—Dyspnoea—Metformin—polycystic ovary syndrome	0.00502	0.00692	CcSEcCtD
Esomeprazole—Somnolence—Metformin—polycystic ovary syndrome	0.00501	0.0069	CcSEcCtD
Esomeprazole—Dyspepsia—Metformin—polycystic ovary syndrome	0.00496	0.00684	CcSEcCtD
Esomeprazole—Decreased appetite—Metformin—polycystic ovary syndrome	0.0049	0.00675	CcSEcCtD
Esomeprazole—CYP2C19—endocrine gland—polycystic ovary syndrome	0.0049	0.0338	CbGeAlD
Esomeprazole—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00487	0.0067	CcSEcCtD
Esomeprazole—Fatigue—Metformin—polycystic ovary syndrome	0.00486	0.00669	CcSEcCtD
Esomeprazole—Constipation—Metformin—polycystic ovary syndrome	0.00482	0.00664	CcSEcCtD
Esomeprazole—ATP4A—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00475	0.0553	CbGpPWpGaD
Esomeprazole—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00464	0.0064	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00461	0.00635	CcSEcCtD
Esomeprazole—Urticaria—Metformin—polycystic ovary syndrome	0.00448	0.00617	CcSEcCtD
Esomeprazole—Abdominal pain—Metformin—polycystic ovary syndrome	0.00445	0.00614	CcSEcCtD
Esomeprazole—Asthenia—Metformin—polycystic ovary syndrome	0.00404	0.00557	CcSEcCtD
Esomeprazole—Pruritus—Metformin—polycystic ovary syndrome	0.00399	0.00549	CcSEcCtD
Esomeprazole—Diarrhoea—Metformin—polycystic ovary syndrome	0.00386	0.00531	CcSEcCtD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00373	0.0434	CbGpPWpGaD
Esomeprazole—Dizziness—Metformin—polycystic ovary syndrome	0.00373	0.00513	CcSEcCtD
Esomeprazole—Vomiting—Metformin—polycystic ovary syndrome	0.00358	0.00494	CcSEcCtD
Esomeprazole—Rash—Metformin—polycystic ovary syndrome	0.00355	0.0049	CcSEcCtD
Esomeprazole—Dermatitis—Metformin—polycystic ovary syndrome	0.00355	0.00489	CcSEcCtD
Esomeprazole—Headache—Metformin—polycystic ovary syndrome	0.00353	0.00486	CcSEcCtD
Esomeprazole—Nausea—Metformin—polycystic ovary syndrome	0.00335	0.00461	CcSEcCtD
Esomeprazole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0029	0.02	CbGeAlD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00288	0.0335	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00256	0.0299	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00207	0.0242	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00205	0.0239	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00185	0.0216	CbGpPWpGaD
Esomeprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.00183	0.0213	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00183	0.0213	CbGpPWpGaD
Esomeprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.00167	0.0194	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00165	0.0193	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00161	0.0188	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.0016	0.0186	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00115	0.0134	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00115	0.0134	CbGpPWpGaD
Esomeprazole—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00105	0.0122	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.001	0.0117	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000969	0.0113	CbGpPWpGaD
Esomeprazole—CYP2C19—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00088	0.0103	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000846	0.00986	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000774	0.00901	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000719	0.00838	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000692	0.00806	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00069	0.00803	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000673	0.00784	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000658	0.00766	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000654	0.00762	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000641	0.00747	CbGpPWpGaD
Esomeprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000633	0.00737	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000616	0.00718	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000608	0.00708	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000586	0.00683	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000577	0.00672	CbGpPWpGaD
Esomeprazole—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000576	0.00671	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000573	0.00667	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000565	0.00659	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000552	0.00643	CbGpPWpGaD
Esomeprazole—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000529	0.00616	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000509	0.00593	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000499	0.00582	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000492	0.00573	CbGpPWpGaD
Esomeprazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000489	0.0057	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000464	0.00541	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000453	0.00528	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000447	0.00521	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000423	0.00493	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00037	0.00432	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000367	0.00428	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000366	0.00426	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000365	0.00426	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000361	0.0042	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000347	0.00404	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000344	0.00401	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00034	0.00396	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000337	0.00393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000321	0.00374	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0003	0.0035	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0003	0.00349	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000296	0.00345	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000295	0.00344	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000284	0.00331	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000279	0.00325	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000273	0.00318	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000272	0.00317	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000272	0.00317	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000269	0.00313	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000265	0.00309	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000262	0.00305	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000262	0.00305	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000247	0.00288	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000247	0.00287	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000243	0.00283	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000225	0.00262	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000225	0.00262	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000221	0.00257	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000221	0.00257	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00022	0.00256	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000217	0.00253	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000195	0.00227	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000193	0.00225	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000193	0.00224	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000188	0.00219	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00018	0.0021	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000178	0.00208	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000178	0.00208	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000178	0.00207	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00017	0.00198	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000164	0.00191	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00016	0.00186	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000157	0.00183	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000157	0.00183	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000155	0.00181	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000149	0.00173	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000148	0.00173	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000146	0.0017	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000145	0.00169	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000138	0.00161	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000133	0.00155	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000132	0.00154	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000129	0.0015	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000127	0.00147	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000127	0.00147	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000125	0.00146	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000118	0.00137	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000117	0.00137	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000117	0.00137	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000116	0.00135	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000115	0.00134	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000107	0.00125	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000102	0.00119	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.0001	0.00117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.0001	0.00117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.62e-05	0.00112	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.47e-05	0.0011	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	9.46e-05	0.0011	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	9.33e-05	0.00109	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	8.38e-05	0.000977	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	8.32e-05	0.00097	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	7.95e-05	0.000926	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	7.61e-05	0.000887	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	7.61e-05	0.000887	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	7.58e-05	0.000883	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.5e-05	0.000873	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	7.08e-05	0.000824	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.05e-05	0.000822	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	6.76e-05	0.000787	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	6.45e-05	0.000751	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.37e-05	0.000743	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.04e-05	0.000704	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.02e-05	0.000701	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.02e-05	0.000701	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	5.88e-05	0.000685	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	5.75e-05	0.00067	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	5.57e-05	0.000648	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.12e-05	0.000597	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.04e-05	0.000587	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	4.96e-05	0.000578	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	4.78e-05	0.000557	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.78e-05	0.000557	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.59e-05	0.000535	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.57e-05	0.000532	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.56e-05	0.000531	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.54e-05	0.000529	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.5e-05	0.000525	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.28e-05	0.000499	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.22e-05	0.000491	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.06e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.88e-05	0.000452	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.65e-05	0.000425	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.55e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.54e-05	0.000412	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.46e-05	0.000403	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.35e-05	0.00039	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.34e-05	0.000389	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.08e-05	0.000359	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.98e-05	0.000348	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	2.98e-05	0.000347	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.88e-05	0.000335	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.84e-05	0.000331	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.76e-05	0.000322	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.73e-05	0.000318	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.69e-05	0.000313	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.58e-05	0.0003	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.54e-05	0.000296	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.51e-05	0.000292	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.19e-05	0.000256	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.13e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.03e-05	0.000237	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.01e-05	0.000234	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.01e-05	0.000234	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.99e-05	0.000232	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.79e-05	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.71e-05	0.000199	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.62e-05	0.000189	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.51e-05	0.000176	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.22e-05	0.000143	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.21e-05	0.000141	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.2e-05	0.00014	CbGpPWpGaD
